Uterine fibroids — noncancerous tumors that grow on the uterus — are estimated to affect 70% to 80% of women in the U.S. But despite how common they are, the condition remains under-discussed, under-researched and underfunded.
Shrinking a tumor before surgery helped protect a young patient’s voice.
MSK experts took an unconventional approach, using larotrectinib to make a less extensive operation possible. Read about her treatment:
Proton therapy can target tumors with remarkable precision, reducing damage to nearby healthy tissue. @StanfordMed researchers are advancing the technology to make cancer treatment safer, more effective, and more widely accessible.